CHINAAMC Hang Seng Biotech ETF (HKG:3069)
Hong Kong
· Delayed Price · Currency is HKD 12.52
+0.40 (3.30%)
At close: Jun 3, 2025, 4:00 PM HKT
60.31% (1Y)
| Assets | 429.80M |
| Expense Ratio | 0.71% |
| PE Ratio | 18.10 |
| Dividend (ttm) | 0.06 |
| Dividend Yield | 0.49% |
| Ex-Dividend Date | Dec 18, 2024 |
| Payout Frequency | Annual |
| Payout Ratio | n/a |
| 1-Year Return | +54.16% |
| Volume | 1,109,900 |
| Open | 12.32 |
| Previous Close | 12.12 |
| Day's Range | 12.29 - 12.53 |
| 52-Week Low | 7.27 |
| 52-Week High | 12.59 |
| Beta | 0.28 |
| Holdings | 10 |
| Inception Date | Mar 18, 2021 |
About 3069
CHINAAMC Hang Seng Biotech ETF is headquartered in Beijing, China.
Asset Class Equity
Category Health Care
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3069
Provider ChinaAMC
Index Tracked Hang Seng Biotech Index - HKD - Benchmark TR Net
Performance
3069 had a total return of 54.16% in the past year, including dividends. Since the fund's inception, the average annual return has been -14.03%.
Top 10 Holdings
59.02% of assets| Name | Symbol | Weight |
|---|---|---|
| WuXi Biologics (Cayman) Inc. | 2269 | 10.69% |
| BeOne Medicines Ltd. | BEIGF | 9.75% |
| Innovent Biologics, Inc. | 1801 | 8.43% |
| Akeso, Inc. | 9926 | 6.30% |
| CSPC Pharmaceutical Group Limited | 1093 | 4.94% |
| Sino Biopharmaceutical Limited | 1177 | 4.75% |
| Giant Biogene Holding Co., Ltd. | 2367 | 4.00% |
| Zai Lab Limited | 9688 | 3.63% |
| Hansoh Pharmaceutical Group Company Limited | 3692 | 3.56% |
| WuXi AppTec Co., Ltd. | 2359 | 2.96% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 18, 2024 | 0.060 HKD | Dec 31, 2024 |
| Dec 18, 2023 | 0.030 HKD | Dec 29, 2023 |
| Dec 19, 2022 | 0.040 HKD | Dec 30, 2022 |